ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety of oncology indications and disease biology pathways.
Location: United Kingdom, England, Hinxton
Employees: 11-50
Founded date: 2020
Investors 2
| Date | Name | Website |
| 11.11.2023 | Syncona Pa... | synconaltd... |
| 18.05.2023 | Cambridge ... | cic.vc |
Mentions in press and media 4
| Date | Title | Description | Source |
| 04.04.2023 | Cambridge Innovation Capital invests in Mosaic Therapeutics ... | Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding Cambridge Innovat... | cic.vc/new... |
| 04.04.2023 | Mosaic Therapeutics closes $28m series A funding and appoint... | Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sa... | cambridgen... |
| 04.04.2023 | Mosaic Therapeutics Closes $28M Series A Funding | Mosaic Therapeutics, a Cambridge, UK-based oncology therapeutics company, raised $28M in Series A fu... | finsmes.co... |
| - | Mosaic Therapeutics | “Resolving cancer’s complexity” | fastfounde... |